Fabian Sanchis-Gomar
Fabian Sanchis-Gomar
University of Valencia, School of Medicine, Department of Physiology
uv.es üzerinde doğrulanmış e-posta adresine sahip
Alıntı yapanlar
Alıntı yapanlar
Epidemiology of coronary heart disease and acute coronary syndrome
F Sanchis-Gomar, C Perez-Quilis, R Leischik, A Lucia
Annals of translational medicine 4 (13), 2016
Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis
G Lippi, CJ Lavie, F Sanchis-Gomar
Progress in cardiovascular diseases, 2020
Red blood cell distribution width: A simple parameter with multiple clinical applications
GL Salvagno, F Sanchis-Gomar, A Picanza, G Lippi
Critical reviews in clinical laboratory sciences 52 (2), 86-105, 2015
Exercise acts as a drug; the pharmacological benefits of exercise
J Vina, F Sanchis‐Gomar, V Martinez‐Bello, MC Gomez‐Cabrera
British journal of pharmacology 167 (1), 1-12, 2012
Exercise attenuates the major hallmarks of aging
N Garatachea, H Pareja-Galeano, F Sanchis-Gomar, A Santos-Lozano, ...
Rejuvenation research 18 (1), 57-89, 2015
Mitochondrial biogenesis in exercise and in ageing
J Viña, MC Gomez-Cabrera, C Borras, T Froio, F Sanchis-Gomar, ...
Advanced drug delivery reviews 61 (14), 1369-1374, 2009
Health risks and potential remedies during prolonged lockdowns for coronavirus disease 2019 (COVID-19)
G Lippi, BM Henry, C Bovo, F Sanchis-Gomar
Diagnosis 7 (2), 85-90, 2020
Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19)
G Lippi, BM Henry, F Sanchis-Gomar
European Journal of Preventive Cardiology 27 (9), 906-908, 2020
Elite athletes live longer than the general population: a meta-analysis
N Garatachea, A Santos-Lozano, F Sanchis-Gomar, C Fiuza-Luces, ...
Mayo Clinic Proceedings 89 (9), 1195-1200, 2014
Non-steroidal anti-inflammatory drugs as a treatment for Alzheimer’s disease: a systematic review and meta-analysis of treatment effect
M Miguel-Álvarez, A Santos-Lozano, F Sanchis-Gomar, C Fiuza-Luces, ...
Drugs & aging 32 (2), 139-147, 2015
Age associated low mitochondrial biogenesis may be explained by lack of response of PGC-1α to exercise training
F Derbré, MC Gomez-Cabrera, AL Nascimento, F Sanchis-Gomar, ...
Age 34 (3), 669-679, 2012
Inhibition of xanthine oxidase by allopurinol prevents skeletal muscle atrophy: role of p38 MAPKinase and E3 ubiquitin ligases
F Derbre, B Ferrando, MC Gomez-Cabrera, F Sanchis-Gomar, ...
PloS one 7 (10), e46668, 2012
Obesity and outcomes in COVID-19: when an epidemic and pandemic collide
F Sanchis-Gomar, CJ Lavie, MR Mehra, BM Henry, G Lippi
Mayo Clinic Proceedings, 2020
Irisin: a new potential hormonal target for the treatment of obesity and type 2 diabetes
F Sanchis‐Gomar, G Lippi, S Mayero, C Perez‐Quilis, JL García‐Giménez
Journal of diabetes 4 (3), 196-196, 2012
The p38–PGC-1α–irisin–betatrophin axis: Exploring new pathways in insulin resistance
F Sanchis-Gomar, C Perez-Quilis
Adipocyte 3 (1), 67-68, 2014
Hemoglobin point-of-care testing: the HemoCue system
F Sanchis-Gomar, J Cortell-Ballester, H Pareja-Galeano, G Banfi, G Lippi
Journal of laboratory automation 18 (3), 198-205, 2013
Metabolic impacts of confinement during the COVID-19 pandemic due to modified diet and physical activity habits
M Martinez-Ferran, F de la Guía-Galipienso, F Sanchis-Gomar, ...
Nutrients 12 (6), 1549, 2020
‘Adipaging’: ageing and obesity share biological hallmarks related to a dysfunctional adipose tissue
LM Pérez, H Pareja‐Galeano, F Sanchis‐Gomar, E Emanuele, A Lucia, ...
The Journal of Physiology 594 (12), 3187-3207, 2016
Coronavirus disease 2019 (COVID-19): the portrait of a perfect storm
G Lippi, F Sanchis-Gomar, BM Henry
Annals of translational medicine 8 (7), 2020
Physical activity and Alzheimer disease: a protective association
A Santos-Lozano, H Pareja-Galeano, F Sanchis-Gomar, ...
Mayo Clinic Proceedings 91 (8), 999-1020, 2016
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20